Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SI000413 in Patients With Knee Osteoarthritis
NCT01525758Phase 2Unknown
- Sponsor
- Dong-A Pharmaceutical
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SI000413 in osteoarthritis (OA) (4 arms), sponsored by Dong-A Pharmaceutical. Primary endpoint: Korean Western Ontario and McMaster Universities Osteoarthritis Index at 8 weeks. Status: unknown.
02
Drugs
SI000413
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01525758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01525758.